302 related articles for article (PubMed ID: 30579123)
41. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis.
Lord RM; Hebden AJ; Pask CM; Henderson IR; Allison SJ; Shepherd SL; Phillips RM; McGowan PC
J Med Chem; 2015 Jun; 58(12):4940-53. PubMed ID: 25906293
[TBL] [Abstract][Full Text] [Related]
43. Potent Half-Sandwich 16-/18-Electron Iridium(III) and Ruthenium(II) Anticancer Complexes with Readily Available Amine-Imine Ligands.
Guo L; Li P; Li J; Gong Y; Li X; Wen T; Wu X; Yang X; Liu Z
Inorg Chem; 2023 Dec; 62(51):21379-21395. PubMed ID: 38096360
[TBL] [Abstract][Full Text] [Related]
44. Polymeric micelle-mediated delivery of half-sandwich ruthenium(II) complexes with phosphanes derived from fluoroloquinolones for lung adenocarcinoma treatment.
Kołoczek P; Skórska-Stania A; Cierniak A; Sebastian V; Komarnicka UK; Płotek M; Kyzioł A
Eur J Pharm Biopharm; 2018 Jul; 128():69-81. PubMed ID: 29678734
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
[TBL] [Abstract][Full Text] [Related]
46. Half-sandwich ruthenium(II), rhodium(III) and iridium(III) fluorescent metal complexes containing pyrazoline based ligands: DNA binding, cytotoxicity and antibacterial activities.
Nongpiur CGL; Verma AK; Singh RK; Ghate MM; Poluri KM; Kaminsky W; Kollipara MR
J Inorg Biochem; 2023 Jan; 238():112059. PubMed ID: 36345069
[TBL] [Abstract][Full Text] [Related]
47. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
Ye RR; Cao JJ; Tan CP; Ji LN; Mao ZW
Chemistry; 2017 Oct; 23(60):15166-15176. PubMed ID: 28833658
[TBL] [Abstract][Full Text] [Related]
48. Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor.
Yang Y; Gao Y; Sun Y; Zhao J; Gou S
J Med Chem; 2023 Oct; 66(19):13731-13745. PubMed ID: 37788351
[TBL] [Abstract][Full Text] [Related]
49. Organometallic ruthenium and iridium transfer-hydrogenation catalysts using coenzyme NADH as a cofactor.
Betanzos-Lara S; Liu Z; Habtemariam A; Pizarro AM; Qamar B; Sadler PJ
Angew Chem Int Ed Engl; 2012 Apr; 51(16):3897-900. PubMed ID: 22415924
[TBL] [Abstract][Full Text] [Related]
50. Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp
Guo L; Li P; Li J; Gong Y; Li X; Liu Y; Yu K; Liu Z
Inorg Chem; 2023 Sep; 62(37):15118-15137. PubMed ID: 37671819
[TBL] [Abstract][Full Text] [Related]
51. Dual functions of iridium(III) 2-phenylpyridine complexes: Metastasis inhibition and lysosomal damage.
Liu X; Chen S; Ge X; Zhang Y; Xie Y; Hao Y; Wu D; Zhao J; Yuan XA; Tian L; Liu Z
J Inorg Biochem; 2020 Apr; 205():110983. PubMed ID: 31954343
[TBL] [Abstract][Full Text] [Related]
52. Novel half-sandwich iridium OˆC (carbene)-Complexes: In vitro and in vivo tumor growth suppression and pro-apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.
Xu Z; Zhang Y; Zhang S; Jia X; Zhong G; Yang Y; Du Q; Li J; Liu Z
Cancer Lett; 2019 Apr; 447():75-85. PubMed ID: 30673591
[TBL] [Abstract][Full Text] [Related]
53. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
[TBL] [Abstract][Full Text] [Related]
54. Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]
Purushothaman B; Arumugam P; Ju H; Kulsi G; Samson AAS; Song JM
Eur J Med Chem; 2018 Aug; 156():747-759. PubMed ID: 30048924
[TBL] [Abstract][Full Text] [Related]
55. Half-sandwich Iridium
Han Y; Tian Z; Zhang S; Liu X; Li J; Li Y; Liu Y; Gao M; Liu Z
J Inorg Biochem; 2018 Dec; 189():163-171. PubMed ID: 30268969
[TBL] [Abstract][Full Text] [Related]
56. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
57. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
[TBL] [Abstract][Full Text] [Related]
58. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
[TBL] [Abstract][Full Text] [Related]
59. Ruthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cells.
Deng Z; Gao P; Yu L; Ma B; You Y; Chan L; Mei C; Chen T
Biomaterials; 2017 Jun; 129():111-126. PubMed ID: 28340357
[TBL] [Abstract][Full Text] [Related]
60. Configurationally regulated half-sandwich iridium(III)-ferrocene heteronuclear metal complexes: Potential anticancer agents.
Liu X; Wang Z; Zhang X; Lv X; Sun Y; Dong R; Li G; Ren X; Ji Z; Yuan XA; Liu Z
J Inorg Biochem; 2023 Dec; 249():112393. PubMed ID: 37806004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
